ERBB2 and breast carcinoma: The activation of autophagy might constitute a molecularmechanism that, beyond HER2 expression status in breast carcinoma cells, may accurately reflect thereliance of HER2 gene-amplified breast carcinomas on HER2-driven signaling [27-29].